Wikidata

(Q65348302)

English

A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

clinical trial

In more languages

Statements

short name
ANNOUNCE (English)
0 references
title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients With Advanced or Metastatic Soft Tissue Sarcoma (English)
0 references
medical condition
sarcoma
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
United Kingdom
0 references
start time
14 September 2015
0 references
end time
5 December 2018
0 references
number of participants
460
0 references
research intervention
doxorubicin
0 references
Caelyx
0 references
olaratumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65348302&oldid=1858198449"